in this issue
Markets :: Fine Chemicals/Biotech :: Industrial Biotech
Bayer Animal Health Taps into Paraco's Molecules
3:37 AM MDT | July 15, 2010 | Natasha Alperowicz
Bayer Animal Health and Paraco Technology (Palmerston North, New Zealand), a start up biotech company, owned by New Zealand's AgResearch, have signed an option agreement allowing Bayer exclusive access to Paraco's current lead molecules for testing and development in animal health. The focus is on research into parasiticides. Paraco, although supported financially by AgResearch, is keen to raise external funds to allow it to progress its lead molecules quickly, says Ian Boddy, managing director of Paraco. Bayer Animal Health, a part of Bayer HealthCare, had sales...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee